Former biotech CEO Martin Shkreli, right, leaves federal court with a member of his legal team Thursday, July 27, 2017, in New York. Shkreli's defense ...
News
- The Latest: 'Pharma Bro' jury to begin deliberations Monday
- Institute to develop transplant organs for injured vets
Officials say it will bring good jobs to Manchester and give the state's college graduates opportunities to work on cutting-edge biomedical research.
- Facebook and Verizon advance while AstraZeneca dives
... up $2.85 to $133.92. The biotechnology company raised its forecasts after a strong second quarter and said it will cut some research programs.
- The Latest: Lawyer says Shkreli never bilked investors
A defense attorney at the securities fraud trial of former biotech CEO Martin Shkreli says his client didn't rip off investors. Lawyer Ben Brafman told the ...
- In US first, scientists edit genes of human embryos
Hank Greely, director of Stanford University's Center for Law and the Biosciences, called CRISPR "the most exciting thing I've seen in biology in the 25 ...